VISUSTRIN * COLL 10ML 1MG / ML
Hyperemia, itching, burning, conjunctival edema.
Dosage and method of use
Dosage Apply 2 drops in each eye two or three times a day. Do not exceed the recommended dose.
• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. VISUSTRIN should not be used by people with glaucoma or other serious eye diseases and in children under three years of age.
The use of VISUSTRIN can sometimes lead to pupillary dilation, systemic absorption effects (hypertension, heart disease, hyperglycaemia), increased intraocular pressure, nausea, headache. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system of the Italian Medicines Agency at: http://www.agenziafarmaco.gov.it/it/responsabili
If symptoms persist or worsen after a short period of treatment, consult your doctor; in any case, the product should not be used for more than four consecutive days, given the possibility that unwanted effects may otherwise occur. Infections, pus, foreign bodies in the eye, mechanical, chemical, heat damage require medical attention. The product, although having poor systemic absorption, should be used with caution in patients suffering from hypertension, hyperthyroidism, cardiac disorders and hyperglycemia (diabetes) and in subjects undergoing treatment with antidepressant drugs. For those who carry out sporting activities: the use of the drug without necessity constitutes doping and can in any case determine positive anti-doping tests. May cause eye irritation. Avoid contact with soft contact lenses. Remove contact lenses before application and wait at least 15 minutes before reapplying. The bleaching action against soft contact lenses is known. Follow the recommended doses scrupulously. The product, if accidentally ingested or if used for a long period in excessive doses, can cause toxic phenomena. Not getting relief within 48 hours of starting treatment, discontinue use and perform a thorough ophthalmological examination. Pediatric population VISUSTRIN should be kept out of the reach of children as accidental ingestion can cause marked sedation. Safety and efficacy in children have not been established. Use in children over three years of age should be evaluated by the physician.
Pregnancy and breastfeeding
In pregnant or breastfeeding women, the medicine should be administered in cases of real need, under the direct supervision of the doctor.
Expiry and retention
To be kept at a temperature not exceeding 25 ° C.
Interactions with other drugs
In case of overdose, discontinue treatment and initiate appropriate therapy.
10 ml of eye drops contain: Active ingredient: 10 mg tetrizoline hydrochloride. For the full list of excipients, see section 6.1.
Excipients: boric acid; sodium chloride; borax; benzalkonium chloride; sodium edetate; purified water.